Platinum-based chemotherapy plus immune checkpoint inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Platinum-based chemotherapy plus immune checkpoint inhibitors, covering 2024-06-07 to 2024-06-07. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer [Phase 2]